Claytor Renee, Lile Joshua A, Nader Michael A
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1083, USA.
Pharmacol Biochem Behav. 2006 Mar;83(3):456-64. doi: 10.1016/j.pbb.2006.03.007. Epub 2006 May 2.
The dopamine D3 receptor is mainly expressed in regions of the brain associated with the limbic system. D3 receptor blockade may antagonize cocaine reinforcement while producing less severe extrapyramidal side effects than blockade of D2 receptors. The purpose of the present studies was to evaluate the effects of a selective D3 receptor antagonist and a non-selective D2/D3 receptor antagonist on food- and cocaine-maintained responding under two schedules of cocaine self-administration. Adult male rhesus monkeys were trained to respond under multiple schedules of food (1.0 g pellets) and cocaine (0.01-0.3 mg/kg/injection) presentation. In one experiment (n=4), the schedule was a fixed-interval (FI) 3-min and a second study (n=6) was conducted using a second-order fixed-ratio 5 (FI 6-min:S) schedule. The D3 antagonist PNU 99194-A (0.3-3.0 mg/kg), which is 14-fold selective for D3 relative to D2 receptors, or the D2/D3 antagonist eticlopride (0.001-0.03 mg/kg) was administered immediately prior to the experimental session for at least 5 consecutive sessions. Under the multiple FI 3-min schedule of food and cocaine presentation, PNU 99194-A and eticlopride decreased food- and cocaine-maintained responding in a dose-dependent manner and irrespective of cocaine dose. Under the multiple second-order schedule of food and cocaine presentation, at least one dose of PNU 99194-A and eticlopride decreased cocaine- and food-maintained responding. These findings indicate that PNU 99194-A can decrease operant responding in monkeys, but not in a manner that would suggest selectivity of cocaine- over food-maintained responding. Future studies with more selective D3 antagonists are needed to better address the role of this receptor subtype in cocaine addiction.
多巴胺D3受体主要表达于与边缘系统相关的脑区。D3受体阻断可能拮抗可卡因强化作用,同时与D2受体阻断相比产生的锥体外系副作用较轻。本研究的目的是评估一种选择性D3受体拮抗剂和一种非选择性D2/D3受体拮抗剂在两种可卡因自我给药方案下对食物和可卡因维持反应的影响。成年雄性恒河猴接受训练,在食物(1.0克颗粒)和可卡因(0.01 - 0.3毫克/千克/注射)呈现的多种方案下做出反应。在一个实验(n = 4)中,方案为固定间隔(FI)3分钟,第二个研究(n = 6)使用二阶固定比率5(FI 6分钟:S)方案进行。在实验时段前立即给予相对于D2受体对D3具有14倍选择性的D3拮抗剂PNU 99194 - A(0.3 - 3.0毫克/千克)或D2/D3拮抗剂依托必利(0.001 - 0.03毫克/千克),连续至少5个实验时段。在食物和可卡因呈现的多种FI 3分钟方案下,PNU 99194 - A和依托必利以剂量依赖方式降低食物和可卡因维持的反应,且与可卡因剂量无关。在食物和可卡因呈现的多种二阶方案下,至少一个剂量的PNU 99194 - A和依托必利降低了可卡因和食物维持的反应。这些发现表明,PNU 99194 - A可降低猴子的操作性反应,但并非以表明对可卡因维持反应而非食物维持反应具有选择性的方式。需要用更具选择性的D3拮抗剂进行未来研究,以更好地阐明该受体亚型在可卡因成瘾中的作用。